Genome Editing with IscB-ωRNA
“In new research, Cornell scientists provide an explanation for how this problem [i.e. the large size of [MORE]
How long doe gene editing last?
“. . . Intellia [Cambridge, MA] is presenting additional data from the phase 1 trial [MORE]
Gene Editing of Endothelial Cells
“To target endothelium for robust genome editing, we developed poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-b-PLGA) copolymer-based nanoparticle [MORE]
Enhanced prime editing systems
“Toward the goal of enabling a wide range of sequence changes, we [a collaboration of Broad Institute, [MORE]
Implant scaffold with engineered cells release drug to treat inflammation
Building on their work with anti-inflammatory cartilage cells, researchers at Washington [MORE]
CRISPR therapy for rare blood diseases
“Back in 2019 the first CRISPR human clinical trials kicked off in the United States. [MORE]
CRISPR-LIGHT tool for genetic screening tool for organoids
CRIPSR-Lineage Tracing at Cellular resolution in Heterogeneous Tissue (CRISPR-LICHT) is the term researchers [MORE]
Crispr Cas9 molecular scissors
Computational biologists at the Institute for Basic Science (Daejeon, South Korea) have identified thirteen different variations of [MORE]
Genetic modifiers science chart
“Based in San Francisco, Maze Therapeutics (Maze) is studying modifier genes—genes that affect the phenotype or physical [MORE]
Genetically engineered plasmid with-CRISPR-Cas9 removes-Antibiotic Resistance Gene
In a collaboration between plasmid engineers at the University of Colorado SOM and the [MORE]
CRISPR Cas9
Seven years after CRISPR-Cas9 gene editing appeared, clinical trials have begun. The University of Pennsylvania has treated two patients, [MORE]
Crispr Cas9 protein RNA complex
Heretofore, most of the news about CRISPR was about gene editing, unintended off targeting, and the [MORE]
Multiple myeloma cells
Calling the first use of CRISPR gene editing to treat cancer “a genetic Sputnik”, though this time it [MORE]
CRISPR Cas9 Editing_ of the Genome
Scientists at the Wake Forest Institute for Regenerative Medicine have figured out how to control [MORE]